Pulse lineResearch With Heart Logo

ARIC Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Bis JC, DeCarli C, Smith A V, et al. "Common variants at 12q14 and 12q24 are associated with hippocampal volume." Nat Genet. 2012;44(5):545-51.
Soranzo N, Sanna S, Wheeler E, et al. "Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways." Diabetes. 2010;59(12):3229-39.
Do R, Willer CJ, Schmidt EM, et al. "Common variants associated with plasma triglycerides and risk for coronary artery disease." Nat Genet. 2013;45(11):1345-52.
Ilkhanoff L, Arking DE, Lemaitre RN, et al. "A common SCN5A variant is associated with PR interval and atrial fibrillation among African Americans." J Cardiovasc Electrophysiol. 2014;25(11):1150-7.
Assimes TL, Knowles JW, Priest JR, et al. "Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease." Hum Genet. 2008;123(4):399-408.
Sharma R, Matsushita K, Wu A, et al. "Common Medications and Intracerebral Hemorrhage: The ARIC Study." J Am Heart Assoc. 2021;10(5):e014270.
Deo R, Nalls MA, Avery CL, et al. "Common genetic variation near the connexin-43 gene is associated with resting heart rate in African Americans: a genome-wide association study of 13,372 participants." Heart Rhythm. 2013;10(3):401-8.
Armstrong NJ, Mather KA, Sargurupremraj M, et al. "Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities." Stroke. 2020;51(7):2111-2121.
Wirka RC, Gore S, Van Wagoner DR, et al. "A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation." Circ Arrhythm Electrophysiol. 2011;4(1):87-93.
Macri V, Brody JA, Arking DE, et al. "Common Coding Variants in Are Associated With the Nav1.8 Late Current and Cardiac Conduction." Circ Genom Precis Med. 2018;11(5):e001663.
Nambi V, Chambless L, He M, et al. "Common carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study." Eur Heart J. 2012;33(2):183-90.
Thorgeirsson TE, Gudbjartsson DF, Sulem P, et al. "A common biological basis of obesity and nicotine addiction." Transl Psychiatry. 2013;3:e308.
Johnsen JM, Auer PL, Morrison AC, et al. "Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project." Blood. 2013;122(4):590-7.
Lin H, van Setten J, Smith AV, et al. "Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval." Circ Genom Precis Med. 2018;11(5):e002037.
McPherson R, Pertsemlidis A, Kavaslar N, et al. "A common allele on chromosome 9 associated with coronary heart disease." Science. 2007;316(5830):1488-91.
Gore MOdette, Ayers CR, Khera A, et al. "Combining Biomarkers and Imaging for Short-Term Assessment of Cardiovascular Disease Risk in Apparently Healthy Adults." J Am Heart Assoc. 2020;9(15):e015410.
Wang H, Nandakumar P, Tekola-Ayele F, et al. "Combined linkage and association analysis identifies rare and low frequency variants for blood pressure at 1q31." Eur J Hum Genet. 2019;27(2):269-277.
Waheed S, Matsushita K, Sang Y, et al. "Combined association of albuminuria and cystatin C-based estimated GFR with mortality, coronary heart disease, and heart failure outcomes: the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2012;60(2):207-16.
Oelsner EC, Allen NBai, Ali T, et al. "Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design." medRxiv. 2021.
Travis RC, Perez-Cornago A, Appleby PN, et al. "A Collaborative Analysis of Individual Participant Data from 19 Prospective Studies Assesses Circulating Vitamin D and Prostate Cancer Risk." Cancer Res. 2019;79(1):274-285.
Barros SP, Suruki R, Loewy ZG, Beck JD. "A cohort study of the impact of tooth loss and periodontal disease on respiratory events among COPD subjects: modulatory role of systemic biomarkers of inflammation." PLoS One. 2013;8(8):e68592.
Nieto FJ, Adam E, Sorlie P, et al. "Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis." Circulation. 1996;94(5):922-7.
Matsushita K, Ballew SH, Astor BC, et al. "Cohort profile: the chronic kidney disease prognosis consortium." Int J Epidemiol. 2013;42(6):1660-8.
Rawlings AM, Sharrett ARichey, Mosley TH, Wong DF, Knopman DS. "Cognitive Reserve in Midlife is not Associated with Amyloid-β Deposition in Late-Life." J Alzheimers Dis. 2019;68(2):517-521.
Suri FMK, Zhou J, Qiao Y, et al. "Cognitive impairment and intracranial atherosclerotic stenosis in general population." Neurology. 2018;90(14):e1240-e1247.
de Moraes S A, Szklo M, Tilling K, Sato R, Knopman D. "Cognitive functioning as a predictor of ischemic stroke incidence." Epidemiology. 2003;14(6):673-9.
Abraham AG, Guo X, Arsiwala LT, et al. "Cognitive decline in older adults: What can we learn from optical coherence tomography (OCT)-based retinal vascular imaging?" J Am Geriatr Soc. 2021;69(9):2524-2535.
Naorungroj S, Slade GD, Beck JD, Mosley TH, Gottesman RF, Alonso A. "Cognitive decline and oral health in middle-aged adults in the ARIC study." J Dent Res. 2013;92(9):795-801.
Schneider ALC, Gottesman RF, Mosley T, et al. "Cognition and incident dementia hospitalization: results from the atherosclerosis risk in communities study." Neuroepidemiology. 2013;40(2):117-24.
West NA, Johnson DA, Lutsey PL, Mosley TH, Redline S. "Cognition and 20-year subsequent sleep disturbances." Sleep Health. 2021.
Nettleton JA, Follis JL, Schabath MB. "Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 2009;169(12):1445-53.
Tommerdahl KL, Hu EA, Selvin E, et al. "Coffee Consumption May Mitigate the Risk for Acute Kidney Injury: Results From the Atherosclerosis Risk in Communities Study." Kidney Int Rep. 2022;7(7):1665-1672.
Nieto FJ, Comstock GW, Chambless LE, Malinow RM. "Coffee consumption and plasma homocyst(e)ine: results from the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 1997;66(6):1475-7.
Hu EA, Lazo M, Selvin E, et al. "Coffee consumption and liver-related hospitalizations and deaths in the ARIC study." Eur J Clin Nutr. 2019;73(8):1133-1140.
Hu EA, Selvin E, Grams ME, Steffen LM, Coresh JJ. "Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2018;72(2):214-222.
Paynter NP, Yeh H-C, Voutilainen S, et al. "Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study." Am J Epidemiol. 2006;164(11):1075-84.
Cushman M, O'Meara ES, Folsom AR, Heckbert SR. "Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology." Blood. 2009;114(14):2878-83.
Tsai AW, Cushman M, Rosamond WD, et al. "Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)." Am J Med. 2002;113(8):636-42.
Yamagishi K, Aleksic N, Hannan PJ, Folsom AR. "Coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin and risk of coronary heart disease." J Atheroscler Thromb. 2010;17(4):402-9.
Schmidt MI, Watson RL, Duncan BB, et al. "Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators." Metabolism. 1996;45(6):699-706.
Uddin MDMesbah, Nguyen NQuynh H, Yu B, et al. "Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease." Nat Commun. 2022;13(1):5350.
Bhattacharya R, Zekavat SM, Haessler J, et al. "Clonal Hematopoiesis Is Associated With Higher Risk of Stroke." Stroke. 2022;53(3):788-797.
Mok Y, Ishigami J, Sang Y, et al. "Clinically Recognized Varicose Veins and Physical Function in Older Individuals: The ARIC Study." J Gerontol A Biol Sci Med Sci. 2022;77(8):1637-1643.
Wattanakit K, Folsom AR, Duprez DA, Weatherley BD, Hirsch AT. "Clinical significance of a high ankle-brachial index: insights from the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2007;190(2):459-64.
Chamberlain AM, Agarwal SK, Folsom AR, et al. "A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study)." Am J Cardiol. 2011;107(1):85-91.
Yang EY, Nambi V, Tang Z, et al. "Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) study." J Am Coll Cardiol. 2009;54(25):2388-95.
Chunawala ZS, Fudim M, Arora S, et al. "Clinical and Echocardiographic Characteristics of Patients Hospitalized With Acute Versus Chronic Heart Failure With Preserved Ejection Fraction (From the ARIC Study)." Am J Cardiol. 2021.
Rosamond WD, Chang PP, Baggett C, et al. "Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria." Circ Heart Fail. 2012;5(2):152-9.
Loehr LR, Agarwal SK, Baggett C, et al. "Classification of acute decompensated heart failure: an automated algorithm compared with a physician reviewer panel: the Atherosclerosis Risk in Communities study." Circ Heart Fail. 2013;6(4):719-26.
Ishigami J, Sumida K, Grams ME, et al. "CKD and Risk of Incident Hospitalization With Clostridioides difficile Infection: Findings From the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2022;80(2):297-299.
Hui X, Matsushita K, Sang Y, Ballew SH, Fulop T. "CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race." Am J Kidney Dis. 2013;62(4):691-702.
Hoogeveen RC, Ballantyne CM, Bang H, et al. "Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study." Diabetologia. 2007;50(1):36-42.
Georgakis MK, Malik R, Björkbacka H, et al. "Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 Individuals." Circ Res. 2019;125(8):773-782.
Alonso A, Misialek JR, Amiin MA, et al. "Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort." Heart. 2014;100(19):1511-6.
Alonso A, Misialek JR, Eckfeldt JH, et al. "Circulating fibroblast growth factor-23 and the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities study." J Am Heart Assoc. 2014;3(5):e001082.
Alonso A, Rooney MR, Chen LYee, et al. "Circulating electrolytes and the prevalence of atrial fibrillation and supraventricular ectopy: The Atherosclerosis Risk in Communities (ARIC) study." Nutr Metab Cardiovasc Dis. 2020;30(7):1121-1129.
de Larriva APArenas, Alonso A, Norby FL, Roetker NS. "Circulating ceruloplasmin, ceruloplasmin-associated genes and the incidence of venous thromboembolism in the Atherosclerosis Risk in Communities study." J Thromb Haemost. 2019;17(5):818-826.
de Larriva APArenas, Norby FL, Chen LYee, et al. "Circulating ceruloplasmin, ceruloplasmin-associated genes, and the incidence of atrial fibrillation in the atherosclerosis risk in communities study." Int J Cardiol. 2017;241:223-228.
Folsom AR, Yao L, Alonso A, et al. "Circulating Biomarkers and Abdominal Aortic Aneurysm Incidence: The Atherosclerosis Risk in Communities (ARIC) Study." Circulation. 2015;132(7):578-85.
Prizment AE, Linabery AM, Lutsey PL, et al. "Circulating Beta-2 Microglobulin and Risk of Cancer: The Atherosclerosis Risk in Communities Study (ARIC)." Cancer Epidemiol Biomarkers Prev. 2016;25(4):657-64.
Hwang SJ, Ballantyne CM, Sharrett AR, et al. "Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study." Circulation. 1997;96(12):4219-25.
Ding N, Sang Y, Chen J, et al. "Cigarette Smoking, Smoking Cessation, and Long-Term Risk of 3 Major Atherosclerotic Diseases." J Am Coll Cardiol. 2019;74(4):498-507.
Ding N, Shah AM, Blaha MJ, Chang PP, Rosamond WD, Matsushita K. "Cigarette Smoking, Cessation, and Risk of Heart Failure With Preserved and Reduced Ejection Fraction." J Am Coll Cardiol. 2022;79(23):2298-2305.
Howard G, Wagenknecht LE, Burke GL, et al. "Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study." JAMA. 1998;279(2):119-24.
Howard G, Wagenknecht LE, Cai J, Cooper L, Kraut MA, Toole JF. "Cigarette smoking and other risk factors for silent cerebral infarction in the general population." Stroke. 1998;29(5):913-7.
Zhang L, Samet J, Caffo B, Punjabi NM. "Cigarette smoking and nocturnal sleep architecture." Am J Epidemiol. 2006;164(6):529-37.
Sonsin-Diaz N, Gottesman RF, Fracica E, Walston J, B Windham G, Knopman DS. "Chronic Systemic Inflammation Is Associated With Symptoms of Late-Life Depression: The ARIC Study." Am J Geriatr Psychiatry. 2020;28(1):87-98.
Sanders AE, Sofer T, Wong Q, et al. "Chronic Periodontitis Genome-wide Association Study in the Hispanic Community Health Study / Study of Latinos." J Dent Res. 2017;96(1):64-72.
Rhodin K, Divaris K, North KE, Barros SP, Moss K, Beck JD. "Chronic periodontitis genome-wide association studies: gene-centric and gene set enrichment analyses." J Dent Res. 2014;93(9):882-90.
Matsushita K, Kwak L, Ballew SH, et al. "Chronic kidney disease measures and the risk of abdominal aortic aneurysm." Atherosclerosis. 2018;279:107-113.
Lamprea-Montealegre JA, Sharrett ARichey, Matsushita K, Selvin E, Szklo M. "Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study." Atherosclerosis. 2014;234(1):42-6.
Alonso A, Lopez FL, Matsushita K, et al. "Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study." Circulation. 2011;123(25):2946-53.
Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR. "Chronic kidney disease increases risk for venous thromboembolism." J Am Soc Nephrol. 2008;19(1):135-40.
Folsom AR, Lutsey PL, Astor BC, Wattanakit K, Heckbert SR, Cushman M. "Chronic kidney disease and venous thromboembolism: a prospective study." Nephrol Dial Transplant. 2010;25(10):3296-301.
Ishigami J, Grams ME, Naik RP, Coresh JJ. "Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study." Clin J Am Soc Nephrol. 2016;11(10):1735-1743.
Luft VC, Schmidt MI, Pankow JS, Couper DJ, Ballantyne CM, Young HJ. "Chronic inflammation role in the obesity-diabetes association: a case-cohort study." Diabetol Metab Syndr. 2013;5(1):31.
Rubin J, Matsushita K, Ballantyne CM, Hoogeveen R, Coresh J, Selvin E. "Chronic hyperglycemia and subclinical myocardial injury." J Am Coll Cardiol. 2012;59(5):484-9.
Natarajan P, Pampana A, Graham SE, et al. "Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices." Nat Commun. 2021;12(1):2182.
Nieto FJ, Folsom AR, Sorlie PD, Grayston JT, Wang SP, Chambless LE. "Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study." Am J Epidemiol. 1999;150(2):149-56.
Wang QY, Song J, Gibbs RA, Boerwinkle E, Dong JF, Yu FL. "Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes." J Thromb Haemost. 2013;11(2):261-9.